We invite you to participate in this survey (< 15 min) created as part of the ESTRO Physics workshop 2025, which aims to gain an overview of the current status and maturity of 3D printing applications in radiotherapy, as well as gather insights into the future potential of this technology.

Our target audience includes radiotherapy professionals with diverse backgrounds who are currently working with or planning to work with 3D printing in the future.

Today, the majority of radiotherapy centres in Europe already have access to 3D printing and use this technology in one way or another. 3D printing has the potential to create substantial added value for radiation oncology, offering improved precision and customisation in patient care. Despite its growing availability and the decreasing cost of the technology, which makes it more accessible than ever, there remains a significant gap in standardisation and knowledge exchange among medical physicists and engineers working with these innovations. As a result, the potential of 3D printing is still underutilised, in part due to siloed initiatives and the additional complexities introduced by the Medical Device Regulation.

The workshop titled “3D Printing in Radiation Oncology: Steps Toward a More General Application in Clinical Practice” aims to bridge these gaps. By fostering collaboration and knowledge sharing, we can overcome current barriers to widespread adoption. In this context, we warmly invite you to participate in a survey. Although this is a European initiative, we also aim to gather insights from countries outside Europe to build a broader understanding of current practices and needs across centres worldwide.


For questions and suggestions:

Tom Depuydt email: tom.depuydt@uzleuven.be
Gabriel Fonseca email: gabriel.paivafonseca@maastro.nl


Data Privacy Disclaimer

No personal data or institutional names will be shared in any publication or report. We ask for your country and city only to ensure that responses are not biased by multiple participants from the same institution.

Providing the institution name, country, city, and professional role is mandatory, but:

  • The city name and institution will remain confidential and will not be reported.
  • Some aggregated results by country may be presented in the final analysis.
  • Some aggregated results by professional role may be presented in the final analysis.

Results are intended to be published as part of an open-access peer-reviewed paper to support future use of 3D printing in radiotherapy.
 
10% of survey complete.

Question Title

1. Institution (Required.)

Question Title

2. Institution country (Required.)

Question Title

3. Institution city (Required.)

Question Title

4. Professional Role (Required.)

Question Title

5. Hospital type (or University/Research centre)

Question Title

6. Annual number of patients. Please provide an approximate number.

If your centre does not have a certain modality, enter 0.
If you don’t know the number, leave the field blank.

Additional considerations can be added in the comment box below. Please mention if a certain modality is used as a boost (e.g., Photons + Electrons or EBRT + Brachy)

Question Title

7. Please add any additional considerations related to the previous item (if any).

Question Title

8. Are you currently using 3D printing? (Required.)

T